Cargando…

Tecovirimat Resistance in Mpox Patients, United States, 2022–2023

During the 2022 multinational outbreak of monkeypox virus (MPXV) infection, the antiviral drug tecovirimat (TPOXX; SIGA Technologies, Inc., https://www.siga.com) was deployed in the United States on a large scale for the first time. The MPXV F13L gene homologue encodes the target of tecovirimat, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Todd G., Gigante, Crystal M., Wynn, Nhien T., Matheny, Audrey, Davidson, Whitni, Yang, Yong, Condori, Rene Edgar, O’Connell, Kyle, Kovar, Lynsey, Williams, Tracie L., Yu, Yon C., Petersen, Brett W., Baird, Nicolle, Lowe, David, Li, Yu, Satheshkumar, Panayampalli S., Hutson, Christina L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683829/ https://www.ncbi.nlm.nih.gov/pubmed/37856204 http://dx.doi.org/10.3201/eid2912.231146

Ejemplares similares

Tecovirimat for the treatment of severe Mpox in Germany
por: Hermanussen, Lennart, et al.
Publicado: (2023)

Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June–September 2022
por: Minhaj, Faisal S., et al.
Publicado: (2023)

2684. Characteristics of mpox patients treated with Tecovirimat: a single center review
por: Vargas, Robert, et al.
Publicado: (2023)

Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022
por: Contag, Caitlin A., et al.
Publicado: (2023)

1790. Characteristics of Patients with Mpox Treated with Tecovirimat during the 2022 Outbreak in Puerto Rico
por: Gonzalez, Hector J Melendez, et al.
Publicado: (2023)

Interim Clinical Treatment Considerations for Severe Manifestations of Mpox — United States, February 2023
por: Rao, Agam K., et al.
Publicado: (2023)

Tecovirimat use among patients with monkeypox (mpox) in Alameda County, California, June–October 2022
por: Ouyang, Megan, et al.
Publicado: (2023)

The CDC Domestic Mpox Response — United States, 2022–2023
por: McQuiston, Jennifer H., et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System
por: Vo, Christopher, et al.
Publicado: (2023)

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
por: Lash, Maura K., et al.
Publicado: (2023)

Notes from the Field: Emergence of an Mpox Cluster Primarily Affecting Persons Previously Vaccinated Against Mpox — Chicago, Illinois, March 18–June 12, 2023
por: Faherty, Emily A. G., et al.
Publicado: (2023)

Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022)

Antiviral activities of two nucleos(t)ide analogs against vaccinia and mpox viruses in primary human fibroblasts
por: Dsouza, Lara, et al.
Publicado: (2023)

Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts
por: Dsouza, Lara, et al.
Publicado: (2023)

Monkeypox treatment: Is tecovirimat the answer?
por: Niaz, Faizan, et al.
Publicado: (2022)

Overview of Mpox Outbreak in Greece in 2022–2023: Is It Over?
por: Mellou, Kassiani, et al.
Publicado: (2023)

Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report
por: Martinez, Andres E., et al.
Publicado: (2023)

Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023
por: Hoxha, Ana, et al.
Publicado: (2023)

Using the LN34 Pan-Lyssavirus Real-Time RT-PCR Assay for Rabies Diagnosis and Rapid Genetic Typing from Formalin-Fixed Human Brain Tissue
por: Condori, Rene Edgar, et al.
Publicado: (2020)

Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public–private hospital partnership during the 2022 NYC mpox outbreak
por: Mgbako, Ofole, et al.
Publicado: (2023)

Possible Undetected Mpox Infection Among Persons Accessing Homeless Services and Staying in Encampments — San Francisco, California, October–November 2022
por: Waddell, Caroline J., et al.
Publicado: (2023)

Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023)

Monkeypox Proctitis: A Case of Targeted Treatment With Tecovirimat
por: Patel, Premalkumar, et al.
Publicado: (2023)

Clinical, epidemiological, and virological features of Mpox in Beijing, China – May 31–June 21, 2023
por: Dou, Xiangfeng, et al.
Publicado: (2023)

Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat
por: Hernandez, Loren E, et al.
Publicado: (2022)

Tecovirimat for Monkeypox in the Central African Republic under Expanded Access
por: Mbrenga, Festus, et al.
Publicado: (2022)

Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge()()
por: Russo, Andrew T., et al.
Publicado: (2020)

Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the Congo
por: Pittman, Phillip R., et al.
Publicado: (2023)

Le técovirimat dans le traitement de la variole simienne
por: Halani, Sheliza, et al.
Publicado: (2023)

In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat
por: Nunes, Desiree dos Santos, et al.
Publicado: (2023)

Mpox respiratory transmission: the state of the evidence
por: Beeson, Amy, et al.
Publicado: (2023)

Prevalence of Asymptomatic Mpox among Men Who Have Sex with Men, Japan, January–March 2023
por: Mizushima, Daisuke, et al.
Publicado: (2023)

Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
por: Matias, Wilfredo R, et al.
Publicado: (2022)

Monkeypox infection and resolution after treatment with tecovirimat in two patients with HIV disease
por: Beatty, Norman L., et al.
Publicado: (2022)

Epidemiology of Human Mpox — Worldwide, 2018–2021
por: McCollum, Andrea M., et al.
Publicado: (2023)

Epidemiologic and Clinical Features of Mpox-Associated Deaths — United States, May 10, 2022–March 7, 2023
por: Riser, Aspen P., et al.
Publicado: (2023)

Epidemiologic and Clinical Features of Mpox in Adults Aged >50 Years — United States, May 2022–May 2023
por: Eustaquio, Patrick C., et al.
Publicado: (2023)

Effect of Surfactants and Polymers on the Dissolution Behavior of Supersaturable Tecovirimat-4-Hydroxybenzoic Acid Cocrystals
por: Feng, Yumiao, et al.
Publicado: (2021)

Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection
por: Fatima, Maurish, et al.
Publicado: (2023)

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022
por: O’Laughlin, Kevin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_14m5glv5q91gkrjdi9rkr9in2n